Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.74 |
| ▸ | KAT2B | Q92831 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7149998 | 0.94 | MAPT (0.71) | MAPTKAT2BHTTGAAALDH1A1 | |
| SCHEMBL14661687 | 0.92 | MAPT (0.68) | MAPTKAT2BHTTGAAALDH1A1 | |
| SCHEMBL11935541 | 0.92 | MAPT (0.68) | MAPTKAT2BHTTGAAALDH1A1 | |
| SCHEMBL11748511 | 0.89 | MAPT (0.52) | MAPTGAASTK17AALDH1A1PRSS1 | |
| SCHEMBL3297792 | 0.86 | MAPT (0.73) | MAPTHTTGAAALDH1A1HRH3 | |
| SCHEMBL11518048 | 0.86 | MAPT (0.80) | MAPTHTTGAAALDH1A1PRSS1 | |
| SCHEMBL2065837 | 0.86 | MAPT (1.00) | MAPTHTTGAAALDH1A1HRH3 | |
| SCHEMBL13639541 | 0.84 | MAPT (0.70) | MAPTHTTGAAALDH1A1PRSS1 | |
| Hydrochloric Acid SCHEMBL28699276 | 0.84 | MAPT (0.70) | MAPTHTTGAAALDH1A1HRH3 | |
| Hydrochloric Acid SCHEMBL15329323 | 0.84 | MAPT (0.94) | MAPTHTTGAAALDH1A1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3658899-A1 | METHODS FOR DETECTING FILM-FORMING AMINES IN WATER | Chemtreat, Inc. (US) | 2020-06-03 | — | — | EP | disclosed |
| WO-2019023699-A1 | METHODS FOR DETECTING FILM-FORMING AMINES IN WATER | CHEMTREAT, INC (US) | 2019-01-31 | — | — | WO | disclosed |
| US-20120059162-A1 | FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION | ONCOTHERAPY SCIENCE, INC. (JP) | 2012-03-08 | — | — | US | disclosed |
| CN-1271724-A | (2-substituted oxyphenyl) alkane acylamide derivative and hair nourishing agent, skin external use agent | SHISEIDO CO LTD (JP) | 2000-11-01 | — | — | CN | disclosed |
| US-4264494-A | Chromium complex dyestuffs for natural polyamides and synthetic nylons | BASF AKTIENGESELLSCHAFT (DE) | 1981-04-28 | — | — | US | disclosed |
| US-4212801-A | Unsymmetrical 1:2-chromium complexes containing an azo and an azomethine bond | BASF AKTIENGESELLSCHAFT (DE) | 1980-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059162-A1 | FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION | NR0B1, GRK7, NR5A2 | MAPT 4685/4885KAT2B 2521/4885HTT 4176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.